Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Update

Mangoceuticals, Inc. (NASDAQ:MGRX) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 124,200 shares, a decline of 18.8% from the November 15th total of 152,900 shares. Currently, 9.1% of the company’s stock are sold short. Based on an average trading volume of 365,800 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Investors Weigh In On Mangoceuticals

An institutional investor recently bought a new position in Mangoceuticals stock. Ackerman Capital Advisors LLC bought a new position in Mangoceuticals, Inc. (NASDAQ:MGRX) during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 873,356 shares of the company’s stock, valued at approximately $206,000. Ackerman Capital Advisors LLC owned about 3.52% of Mangoceuticals as of its most recent SEC filing. 56.72% of the stock is owned by hedge funds and other institutional investors.

Mangoceuticals Price Performance

Shares of MGRX stock traded down $0.08 on Monday, hitting $2.53. The stock had a trading volume of 24,671 shares, compared to its average volume of 220,664. The business has a 50 day moving average of $9.43 and a 200 day moving average of $50.35. Mangoceuticals has a 12-month low of $2.10 and a 12-month high of $16.80. The stock has a market cap of $6.29 million, a price-to-earnings ratio of -0.45 and a beta of 2.09.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.